Neurocrine Biosciences
S&P 400
$156.22
-0.22%
Delayed · cached 15 min
Frequently asked questions
What sector does Neurocrine Biosciences belong to?
Neurocrine Biosciences operates in the Health Care sector, specifically the Biotechnology industry, and is listed on the US markets.
What is the current share price of NBIX?
As of the latest available quote, NBIX traded at $156.22. This price is delayed and cached for about 15 minutes.
What is the P/E ratio of NBIX?
Neurocrine Biosciences has a price-to-earnings (P/E) ratio of about 22.84. The P/E ratio compares the share price to earnings per share and is most useful when compared with sector peers and the company's own history.
What is the market capitalisation of NBIX?
The market capitalisation of Neurocrine Biosciences is approximately $16.01B.
Is Neurocrine Biosciences profitable?
For its latest reported financial year, Neurocrine Biosciences recorded a net profit margin of about 16.73%.
Does NBIX pay a dividend?
Neurocrine Biosciences does not currently show a dividend yield in our data.
What is the return on equity (ROE) of NBIX?
Neurocrine Biosciences has a return on equity (ROE) of about 12.96%. ROE measures how much profit a company generates relative to shareholders' equity.
What is the 52-week high and low of NBIX?
Over the past 52 weeks, NBIX has traded between a low of $122.14 and a high of $186.12.
These answers are generated from reported financial data and live market figures, for educational and informational purposes only.